Quetiapine versus haloperidol decanoate for long-term treatment of schizophrenia and schizoaffective disorder

被引：0
|
作者：
Glick, I [1 ]
Marder, SR [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
SCHIZOPHRENIA BULLETIN | 2005年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：484 / 484
页数：1
相关论文
共 50 条
  • [31] Non-inferiority of intramuscular aripiprazole versus intramuscular haloperidol for the treatment of agitation associated with schizophrenia/schizoaffective disorder
    Oren, D. A.
    Marcus, R. N.
    Manos, G.
    Carson, W. H.
    McQuade, D.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 451 - 451
  • [32] Improvement in cognitive functioning with long-term quetiapine is superior to haloperidol
    Velligan, DI
    Newcomer, J
    Pultz, J
    Csernansky, J
    Hoff, AL
    Mahurin, R
    Miller, A
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 205 - 205
  • [33] Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
    Schoemaker, J.
    Naber, D.
    Vrijland, P.
    Panagides, J.
    Emsley, R.
    PHARMACOPSYCHIATRY, 2010, 43 (04) : 138 - 146
  • [34] Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia
    Daniel, DG
    Wozniak, P
    Mack, RJ
    McCarthy, BG
    PSYCHOPHARMACOLOGY BULLETIN, 1998, 34 (01) : 61 - 69
  • [35] Haloperidol vs. atypical antipsychotics in the long-term treatment of schizophrenia
    Altamura, C.
    Mauri, M. C.
    Dell'Osso, B.
    Buoli, M.
    Dragogna, F.
    Lietti, L.
    Glick, I.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 213 - 213
  • [36] Risperidone versus olanzapine in the treatment of patients with schizophrenia or schizoaffective disorder
    Brecher, M
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 271 - 271
  • [37] Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder
    Lindenmayer, Jean-Pierre
    Khan, Akbar
    Eerdekens, Marielle
    Van Hove, Ilse
    Kushner, Stuart
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (02) : 138 - 144
  • [38] One year study: efficacy of haloperidol versus risperidone in the treatment of schizoaffective disorder
    Mladenovic, D. Siladji
    Vukic, S. Drezgic
    Golubovic, B.
    Ivezic, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S496 - S497
  • [39] Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: A randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial
    Laties, Alan M.
    Flach, Allan J.
    Baldycheva, Irina
    Rak, Ihor
    Earley, Willie
    Pathak, Sanjeev
    JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (01) : 69 - 79
  • [40] A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia
    Kane, JM
    Davis, JM
    Schooler, N
    Marder, S
    Casey, D
    Brauzer, B
    Mintz, J
    Conley, R
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (04): : 554 - 560
12345